{"id":"NCT00366340","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","briefTitle":"Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.","officialTitle":"A Phase 3, Randomized, Active-Controlled, Double-blind Trial of the Safety, Tolerability, and Immunologic Non-Inferiority of a 13-valent Pneumococcal Conjugate Vaccine Compared to a 7-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in Germany.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-10","primaryCompletion":"2008-08","completion":"2008-08","firstPosted":"2006-08-21","resultsPosted":"2012-08-08","lastUpdate":"2012-08-08"},"enrollment":604,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Vaccines, Pneumococcal"],"interventions":[{"type":"BIOLOGICAL","name":"13-valent pneumococcal conjugate vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"7-valent pneumococcal conjugate vaccine","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to 7-valent pneumococcal conjugate (Prevenar/Prevenar®, 7vPnC), when given concomitantly with Infanrix hexa at 2, 3, 4, months (infant series) and at 11-12 months of age (toddler dose) in Germany.","primaryOutcome":{"measure":"Percentage of Participants Achieving Antibody Level ≥0.35 μg/mL in 13vPnC Group Relative to 7vPnC Group After the 3-Dose Infant Series","timeFrame":"One month after 3-dose infant series (5 months of age)","effectByArm":[{"arm":"13vPnC","deltaMin":98.2,"sd":null},{"arm":"7vPnC","deltaMin":98.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"56 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":51,"countries":["Germany"]},"refs":{"pmids":["21704105"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":300},"commonTop":["Increased sleep","Irritability","Fever ≥38°C but ≤39°C","Tenderness (Any)","Erythema (Any)"]}}